AMRN Recent News Can Amarin Corporation PLC Stop
Post# of 109
Posted On: 03/02/2014 1:52:19 AM
AMRN Recent News
Can Amarin Corporation PLC Stop Burning Cash? Motley Fool - Fri Feb 28, 1:16PM CST
Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations GlobeNewswire - Thu Feb 27, 3:14PM CST
Two Years Less Exclusivity Is the Least of Amarin's Issues Motley Fool - Tue Feb 25, 8:30AM CST
Monday’s Winners and Losers: Celsion Corporation, Celladon Corp, and Amarin Corporation plc Motley Fool - Mon Feb 24, 8:26PM CST
Amarin's Vascepa Gets 3-Year Exclusivity - Analyst Blog Zacks Investment Research - Mon Feb 24, 4:20PM CST
Amarin Loses Bid for Vascepa 5-Year Market Exclusivity at The Street - Mon Feb 24, 6:59AM CST
Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014 GlobeNewswire - Mon Feb 24, 5:00AM CST
Amarin Given 3-Year Exclusivity for Vascepa Motley Fool - Fri Feb 21, 9:05PM CST
Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules GlobeNewswire - Fri Feb 21, 3:01PM CST
Biotech Stocks to Trade for Breakouts: Amarin at The Street - Thu Feb 20, 7:27AM CST
Can Amarin Corporation PLC Stop Burning Cash? Motley Fool - Fri Feb 28, 1:16PM CST
Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations GlobeNewswire - Thu Feb 27, 3:14PM CST
Two Years Less Exclusivity Is the Least of Amarin's Issues Motley Fool - Tue Feb 25, 8:30AM CST
Monday’s Winners and Losers: Celsion Corporation, Celladon Corp, and Amarin Corporation plc Motley Fool - Mon Feb 24, 8:26PM CST
Amarin's Vascepa Gets 3-Year Exclusivity - Analyst Blog Zacks Investment Research - Mon Feb 24, 4:20PM CST
Amarin Loses Bid for Vascepa 5-Year Market Exclusivity at The Street - Mon Feb 24, 6:59AM CST
Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014 GlobeNewswire - Mon Feb 24, 5:00AM CST
Amarin Given 3-Year Exclusivity for Vascepa Motley Fool - Fri Feb 21, 9:05PM CST
Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules GlobeNewswire - Fri Feb 21, 3:01PM CST
Biotech Stocks to Trade for Breakouts: Amarin at The Street - Thu Feb 20, 7:27AM CST
(0)
(0)